Form 4: Abeona Therapeutics CEO Vishwas Seshadri Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Abeona Therapeutics' CEO, Vishwas Seshadri, disposed of shares to cover tax obligations upon vesting of restricted stock.
Summary
- On September 28, 2024, Vishwas Seshadri, CEO of Abeona Therapeutics Inc., disposed of 18,798 shares of common stock to satisfy tax withholding obligations.
- The transaction was executed at a price of $5.89 per share.
- Following the transaction, Seshadri directly owns 904,138 shares of Abeona Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disposal of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/28/2024 | Date of stock disposal transaction. |
| 09/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.